{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-024401","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2023-07-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.979275+00:00","generated_at":"2026-06-13T09:16:16.111449+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oncotelic closes $1.0M debt-to-equity conversion; issues 40 Units with notes and warrants","bullets":["Converted $1.0M of debt via private placement of 40 Units to accredited investors.","Each Unit: $25K convertible note (16% interest, 2-yr, $0.10 conversion) and 250K warrants at $0.12/share.","Total offering up to 200 Units ($5M); placement agent JH Darbie, $150K fees paid.","Securities unregistered, exempt under Rule 506(b); Registration Rights Agreement filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-024401","json":"https://secwatch.observer/filing/0001493152-23-024401.json","markdown":"https://secwatch.observer/filing/0001493152-23-024401.md","text":"https://secwatch.observer/filing/0001493152-23-024401.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315223024401/0001493152-23-024401-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315223024401/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T09:16:16.111449+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}